Pleural effusion as the presentation for primary effusion lymphoma

Surgery

Volumn 123, Issue 5, 1998, Pages 589-591

  Vu, Huan N ^a   Jenkins, Frank W ^a   Swerdlow, Steven H ^a   Locker, Joseph ^a   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIN; DAUNORUBICIN; PREDNISONE; VINCRISTINE SULFATE;

AGED; ARTICLE; CASE REPORT; CHEMOTHERAPY; DISEASE ASSOCIATION; DISEASE COURSE; EPSTEIN BARR VIRUS; HISTOLOGY; HUMAN; HUMAN HERPESVIRUS 8; LYMPH NODE BIOPSY; LYMPHOMA; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; THORACOCENTESIS; TREATMENT OUTCOME;

EID: 0031954749     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.1998.88087     Document Type: Article

References (12)

1. Nador R, Cesarman E, Chadburn A, Dawson D, Ansari M, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-56.
2. Chang Y, Cesarman E, Pessin M, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-69.
3. Bigoni B, Dolcetti R, DeLellis L, Carbone A, Biocchi M, Cassai E, et al. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996;173:542-9.
4. Luppi M, Barozzi P, Maiorana A, Artusi T, Trovato R, Marasca R, et al. Human herpesvirus 8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996;87:3903-9.
5. Locker J, Nalesnik, M. Molecular genetic analysis of lymphoid tumors arising in patients immunosuppressed after organ transplantation. Am J Pathol 1989;135:977-87.
6. Cesarman E, Chang Y, Moore P, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
7. Cesarman E, Nador R, Aozasa K, Delsol G, Said J, Knowles D, et al. Kaposi's sarcoma-associated herpesvirus in non-AIDS-related lymphomas occurring in body cavities. Am J Pathol 1996;149:53-7.
8. Strauchen J, Hauser D, Burnstein D, Jimenez R, Moore P, Chang Y. Body cavity-based malignant lymphoma containing Kaposi's sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann Intern Med 1996;125:822-5.
9. Decker LL, Shankar P, Khan G, Freeman RB, Dezube BJ, Lieberman J, et al. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 1996;184:283-8.
10. Otsuki T, Kumar S, Ensoli B, Kingma DW, Yano T, StetlerStevenson M, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996;10:1358-62.
11. Said J, Chien K, Takeuchi S, Tasaka T, Asou H, Cho S, et al. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood 1996;87:4937-43.
12. Andre S, Schatz O, Bognet J, Zeichhardt H, Stoffler-Meilicke M, Jahn HU, et al. Detection of antibodies against viral capsid proteins of human herpes 8 in AIDS-associated Kaposi's sarcoma. J Mol Med 1997;75:145-52.